Responding to Long COVID Responsibly

To effectively address the unique challenges presented by Long COVID, the Global Virus Network recommends a unified and integrated approach involving the public, policymakers, and those involved in the research enterprise and in healthcare systems to create and implement policy changes, support continuing research, foster awareness, and advocate for‚ÄĒand initiate‚ÄĒmulti-specialty care. *¬† ¬† ¬† ¬†…

Read More

Global Virus Network (GVN) Leaders Publish STAT Op-Ed with a U.S. Government Call to Action and Road Map for the Future of COVID-19

¬†BALTIMORE, MD, January 31, 2023: STAT today published ‚ÄúHow the Biden Administration’s COVID preparedness policies could narrow America’s political divide‚ÄĚ co-authored by leadership of the Global Virus Network (GVN), representing 68 Centers of Excellence and 11 Affiliates in 37 countries, and comprising foremost experts in every class of virus causing disease in humans and some…

Read More

Surge of SARS-CoV-2 Variants in China and USA Further Emphasizes Need for Surveillance, Preparedness, and International Collaborations

BALTIMORE, MD, January 9, 2023: Christian Br√©chot, MD, PhD, President of the Global Virus Network (GVN), Associate Vice President for International Partnerships and Innovation at the University of South Florida and Professor of the Division of Infectious Disease, Department of Internal Medicine at USF Health Morsani College of Medicine, the GVN Southeast U.S. Regional Headquarters…

Read More

GVN Statement on SARS-CoV-2 Variant BF7

SARS-CoV-2 variants continue to appear worldwide. There is some concern about the variant BF7, shorthand for BA.5.2.1.7, which reportedly is spreading in China. BA.5.2.1.7 is part of the Omicron lineage of SARS-CoV-2 and had been indicated as a potential variant of concern.¬†Recent data from the US CDC and other agencies in other countries, however, show…

Read More

GVN Convenes First-of-its-kind Conference to Evaluate the Public Health Magnitude of Long Covid

GVN Convenes First-of-its-kind Conference to Evaluate the Public Health Magnitude of Long Covid and Define a Global Research Roadmap to Address the Crisis World Leaders in Science, Healthcare, Academia, Business and Government Discuss Issues and Ramifications of Long Covid Baltimore, MD, USA (July 22, 2022) ‚Äď The¬†Global Virus Network (GVN), a coalition of world leading…

Read More

Could Viral Persistence Explain Long Covid?

Could Viral Persistence Explain Long Covid?¬† Author: Dr. Reitz June 30, 2022¬† Introduction¬† One serious aspect of Covid is what has been called ‚Äėlong Covid‚ÄĚ, in which various symptoms can persist for as long as a year or more. These can include fatigue, brain fog, loss of taste and/or smell, and cardiovascular problems. There are…

Read More

Global Outbreaks of Monkeypox

May 25, 2022  Introduction  WHO and other health organizations are alarmed at the recent global outbreak of monkeypox. As of May 21, 2022, more than 80 cases of monkeypox have been confirmed in at least 12 countries outside of Africa (1). The first case of the disease in the UK was reported on May 7,…

Read More

Impact of the Omicron variants on the Ongoing Pandemic

Impact of the Omicron variants on the Ongoing Pandemic May 10, 2022 Introduction¬† The emergence of the Omicron variant in November 2021 has led to a rapid surge of COVID-19 cases worldwide. Since then, Omicron has kept evolving into several different sublineages. Furthermore, recombinant Omicron variants have been detected in patients by coinfection with the…

Read More

Specialized Pro-Resolving Mediators (SPMs) as Potential Covid-19 Therapeutic

April 21, 2022 Introduction¬† Our last Perspective described how the timing of the type 1 interferon (IFN) response is a critical early point in determining whether infection with SARS-CoV2 will lead to severe disease or not. IFN activity later in infection, when disease has already developed, is apparently ineffective, and is instead detrimental. Indeed, an…

Read More

Impact of Interferon on Disease Severity of Covid-19

Impact of Interferon on Disease Severity of Covid-19 March 28, 2022 Introduction¬† Types 1 and 3 interferon (IFN) expression and activity have been shown to play a significant role in determining the disease severity of SARS-CoV-2 infection. It is becoming clear that the timing of IFN expression is critical in the efficacy of the early…

Read More